BEVACIZUMAB

82463 reported adverse events

Drug classes: Vascular Endothelial Growth Factor Inhibitor [EPC]

These side effects are most commonly reported by patients taking BEVACIZUMAB:

# Side effect Count
0 DEATH 9861
1 OFF LABEL USE 6201
2 DIARRHOEA 5302
3 DISEASE PROGRESSION 4871
4 NAUSEA 4855
5 FATIGUE 4498
6 HYPERTENSION 4134
7 VOMITING 3824
8 ANAEMIA 2986
9 PYREXIA 2884
See all common reactions for BEVACIZUMAB

BEVACIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 340 0.4293
1 TUMOUR PERFORATION 64 0.3575
2 GASTROINTESTINAL PERFORATION 938 0.3174
3 UROGENITAL FISTULA 36 0.3158
4 GLOMERULAR VASCULAR DISORDER 34 0.3119
5 RECTAL PERFORATION 109 0.2759
6 RETINAL PIGMENT EPITHELIAL TEAR 128 0.2353
7 HEPATIC ATROPHY 85 0.2304
8 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 142 0.2198
9 DIABETIC RETINAL OEDEMA 75 0.2125
See all enriched reactions for BEVACIZUMAB